Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Targeting lipid mediators in cancer biology.

Sulciner ML, Gartung A, Gilligan MM, Serhan CN, Panigrahy D.

Cancer Metastasis Rev. 2018 Sep;37(2-3):557-572. doi: 10.1007/s10555-018-9754-9.

PMID:
30136088
2.

Preface.

Gartung A, Panigrahy D.

Cancer Metastasis Rev. 2018 Sep;37(2-3):201-202. doi: 10.1007/s10555-018-9758-5. No abstract available.

PMID:
30117006
3.

Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via osteopontin.

Chang J, Bhasin SS, Bielenberg DR, Sukhatme VP, Bhasin M, Huang S, Kieran MW, Panigrahy D.

FASEB J. 2018 Jun 29:fj201800019RR. doi: 10.1096/fj.201800019RR. [Epub ahead of print]

PMID:
29957058
4.

Drawing a link between the thromboxane A2 pathway and the role of platelets and tumor cells in ovarian cancer.

Serhan K, Gartung A, Panigrahy D.

Prostaglandins Other Lipid Mediat. 2018 Jul;137:40-45. doi: 10.1016/j.prostaglandins.2018.06.001. Epub 2018 Jun 19. Review.

PMID:
29933028
5.

A common antimicrobial additive increases colonic inflammation and colitis-associated colon tumorigenesis in mice.

Yang H, Wang W, Romano KA, Gu M, Sanidad KZ, Kim D, Yang J, Schmidt B, Panigrahy D, Pei R, Martin DA, Ozay EI, Wang Y, Song M, Bolling BW, Xiao H, Minter LM, Yang GY, Liu Z, Rey FE, Zhang G.

Sci Transl Med. 2018 May 30;10(443). pii: eaan4116. doi: 10.1126/scitranslmed.aan4116.

PMID:
29848663
6.

P and T wave detection and delineation of ECG signal using differential evolution (DE) optimization strategy.

Panigrahy D, Sahu PK.

Australas Phys Eng Sci Med. 2018 Mar;41(1):225-241. doi: 10.1007/s13246-018-0629-8. Epub 2018 Feb 26.

PMID:
29484531
7.

Resolvins suppress tumor growth and enhance cancer therapy.

Sulciner ML, Serhan CN, Gilligan MM, Mudge DK, Chang J, Gartung A, Lehner KA, Bielenberg DR, Schmidt B, Dalli J, Greene ER, Gus-Brautbar Y, Piwowarski J, Mammoto T, Zurakowski D, Perretti M, Sukhatme VP, Kaipainen A, Kieran MW, Huang S, Panigrahy D.

J Exp Med. 2018 Jan 2;215(1):115-140. doi: 10.1084/jem.20170681. Epub 2017 Nov 30.

8.

WEC 2016 special issue editorial.

Panigrahy D, Zeldin DC.

Prostaglandins Other Lipid Mediat. 2017 Sep;132:1-2. doi: 10.1016/j.prostaglandins.2017.09.006. Epub 2017 Sep 18. No abstract available.

PMID:
28928099
9.

Cyclooxygenase-derived proangiogenic metabolites of epoxyeicosatrienoic acids.

Rand AA, Barnych B, Morisseau C, Cajka T, Lee KSS, Panigrahy D, Hammock BD.

Proc Natl Acad Sci U S A. 2017 Apr 25;114(17):4370-4375. doi: 10.1073/pnas.1616893114. Epub 2017 Apr 10.

10.

Reactive Oxygen Species Synergize To Potently and Selectively Induce Cancer Cell Death.

Lee HY, Parkinson EI, Granchi C, Paterni I, Panigrahy D, Seth P, Minutolo F, Hergenrother PJ.

ACS Chem Biol. 2017 May 19;12(5):1416-1424. doi: 10.1021/acschembio.7b00015. Epub 2017 Apr 7.

11.

Extraction of fetal ECG signal by an improved method using extended Kalman smoother framework from single channel abdominal ECG signal.

Panigrahy D, Sahu PK.

Australas Phys Eng Sci Med. 2017 Mar;40(1):191-207. doi: 10.1007/s13246-017-0527-5. Epub 2017 Feb 16.

PMID:
28210991
12.

Soluble epoxide hydrolase deficiency or inhibition enhances murine hypoxic pulmonary vasoconstriction after lipopolysaccharide challenge.

Wepler M, Beloiartsev A, Buswell MD, Panigrahy D, Malhotra R, Buys ES, Radermacher P, Ichinose F, Bloch DB, Zapol WM.

Am J Physiol Lung Cell Mol Physiol. 2016 Dec 1;311(6):L1213-L1221. doi: 10.1152/ajplung.00394.2016. Epub 2016 Nov 4.

13.

Extended Kalman smoother with differential evolution technique for denoising of ECG signal.

Panigrahy D, Sahu PK.

Australas Phys Eng Sci Med. 2016 Sep;39(3):783-95. doi: 10.1007/s13246-016-0468-4. Epub 2016 Aug 19.

PMID:
27542170
14.

Neuropilin 1 Receptor Is Up-Regulated in Dysplastic Epithelium and Oral Squamous Cell Carcinoma.

Shahrabi-Farahani S, Gallottini M, Martins F, Li E, Mudge DR, Nakayama H, Hida K, Panigrahy D, D'Amore PA, Bielenberg DR.

Am J Pathol. 2016 Apr;186(4):1055-64. doi: 10.1016/j.ajpath.2015.11.021. Epub 2016 Feb 11.

15.

FPGA Implementation of Heart Rate Monitoring System.

Panigrahy D, Rakshit M, Sahu PK.

J Med Syst. 2016 Mar;40(3):49. doi: 10.1007/s10916-015-0410-4. Epub 2015 Dec 7.

PMID:
26643079
16.

Epoxyeicosatrienoic acids enhance embryonic haematopoiesis and adult marrow engraftment.

Li P, Lahvic JL, Binder V, Pugach EK, Riley EB, Tamplin OJ, Panigrahy D, Bowman TV, Barrett FG, Heffner GC, McKinney-Freeman S, Schlaeger TM, Daley GQ, Zeldin DC, Zon LI.

Nature. 2015 Jul 23;523(7561):468-71. doi: 10.1038/nature14569.

17.

Editorial: 15th International Winter Eicosanoid Conference.

Panigrahy D, Hammock B.

Prostaglandins Other Lipid Mediat. 2014 Oct;113-115:1. doi: 10.1016/j.prostaglandins.2014.10.004. Epub 2014 Nov 19. No abstract available.

PMID:
25453874
18.

Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis.

Zhang G, Panigrahy D, Hwang SH, Yang J, Mahakian LM, Wettersten HI, Liu JY, Wang Y, Ingham ES, Tam S, Kieran MW, Weiss RH, Ferrara KW, Hammock BD.

Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):11127-32. doi: 10.1073/pnas.1410432111. Epub 2014 Jul 14.

19.

ω-3 polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer.

Wang W, Zhu J, Lyu F, Panigrahy D, Ferrara KW, Hammock B, Zhang G.

Prostaglandins Other Lipid Mediat. 2014 Oct;113-115:13-20. doi: 10.1016/j.prostaglandins.2014.07.002. Epub 2014 Jul 11. Review.

20.

Regulation of soluble neuropilin 1, an endogenous angiogenesis inhibitor, in liver development and regeneration.

Panigrahy D, Adini I, Mamluk R, Levonyak N, Bruns CJ, D'Amore PA, Klagsbrun M, Bielenberg DR.

Pathology. 2014 Aug;46(5):416-23. doi: 10.1097/PAT.0000000000000121.

21.

Time heals all wounds--but 12-HHT is faster.

Gus-Brautbar Y, Panigrahy D.

J Exp Med. 2014 Jun 2;211(6):1008. doi: 10.1084/jem.2116insight1. No abstract available.

22.

In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight.

Dahlman JE, Barnes C, Khan O, Thiriot A, Jhunjunwala S, Shaw TE, Xing Y, Sager HB, Sahay G, Speciner L, Bader A, Bogorad RL, Yin H, Racie T, Dong Y, Jiang S, Seedorf D, Dave A, Sandu KS, Webber MJ, Novobrantseva T, Ruda VM, Lytton-Jean AKR, Levins CG, Kalish B, Mudge DK, Perez M, Abezgauz L, Dutta P, Smith L, Charisse K, Kieran MW, Fitzgerald K, Nahrendorf M, Danino D, Tuder RM, von Andrian UH, Akinc A, Schroeder A, Panigrahy D, Kotelianski V, Langer R, Anderson DG.

Nat Nanotechnol. 2014 Aug;9(8):648-655. doi: 10.1038/nnano.2014.84. Epub 2014 May 11.

23.

Cytochrome P450 2C8 ω3-long-chain polyunsaturated fatty acid metabolites increase mouse retinal pathologic neovascularization--brief report.

Shao Z, Fu Z, Stahl A, Joyal JS, Hatton C, Juan A, Hurst C, Evans L, Cui Z, Pei D, Gong Y, Xu D, Tian K, Bogardus H, Edin ML, Lih F, Sapieha P, Chen J, Panigrahy D, Hellstrom A, Zeldin DC, Smith LE.

Arterioscler Thromb Vasc Biol. 2014 Mar;34(3):581-6. doi: 10.1161/ATVBAHA.113.302927. Epub 2014 Jan 23.

24.

Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression.

Mammoto T, Jiang A, Jiang E, Panigrahy D, Kieran MW, Mammoto A.

Am J Pathol. 2013 Oct;183(4):1293-1305. doi: 10.1016/j.ajpath.2013.06.026. Epub 2013 Aug 5.

25.

Epoxyeicosanoids promote organ and tissue regeneration.

Panigrahy D, Kalish BT, Huang S, Bielenberg DR, Le HD, Yang J, Edin ML, Lee CR, Benny O, Mudge DK, Butterfield CE, Mammoto A, Mammoto T, Inceoglu B, Jenkins RL, Simpson MA, Akino T, Lih FB, Tomer KB, Ingber DE, Hammock BD, Falck JR, Manthati VL, Kaipainen A, D'Amore PA, Puder M, Zeldin DC, Kieran MW.

Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13528-33. doi: 10.1073/pnas.1311565110. Epub 2013 Jul 29.

26.

The growing role of eicosanoids in tissue regeneration, repair, and wound healing.

Kalish BT, Kieran MW, Puder M, Panigrahy D.

Prostaglandins Other Lipid Mediat. 2013 Jul-Aug;104-105:130-8. doi: 10.1016/j.prostaglandins.2013.05.002. Epub 2013 May 28. Review.

PMID:
23727457
27.

Specific uptake of 99mTc-NC100692, an αvβ3-targeted imaging probe, in subcutaneous and orthotopic tumors.

Dearling JL, Barnes JW, Panigrahy D, Zimmerman RE, Fahey F, Treves ST, Morrison MS, Kieran MW, Packard AB.

Nucl Med Biol. 2013 Aug;40(6):788-94. doi: 10.1016/j.nucmedbio.2013.04.006. Epub 2013 May 20.

28.

Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis.

Zhang G, Panigrahy D, Mahakian LM, Yang J, Liu JY, Stephen Lee KS, Wettersten HI, Ulu A, Hu X, Tam S, Hwang SH, Ingham ES, Kieran MW, Weiss RH, Ferrara KW, Hammock BD.

Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6530-5. doi: 10.1073/pnas.1304321110. Epub 2013 Apr 3.

29.

SOCS3 is an endogenous inhibitor of pathologic angiogenesis.

Stahl A, Joyal JS, Chen J, Sapieha P, Juan AM, Hatton CJ, Pei DT, Hurst CG, Seaward MR, Krah NM, Dennison RJ, Greene ER, Boscolo E, Panigrahy D, Smith LE.

Blood. 2012 Oct 4;120(14):2925-9. doi: 10.1182/blood-2012-04-422527. Epub 2012 Jul 12.

30.

Inhibition of neuroblastoma cell proliferation with omega-3 fatty acids and treatment of a murine model of human neuroblastoma using a diet enriched with omega-3 fatty acids in combination with sunitinib.

Barnés CM, Prox D, Christison-Lagay EA, Le HD, Short S, Cassiola F, Panigrahy D, Chaponis D, Butterfield C, Nehra D, Fallon EM, Kieran M, Folkman J, Puder M.

Pediatr Res. 2012 Feb;71(2):168-78. doi: 10.1038/pr.2011.28. Epub 2011 Dec 21.

PMID:
22258128
31.

Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice.

Panigrahy D, Edin ML, Lee CR, Huang S, Bielenberg DR, Butterfield CE, Barnés CM, Mammoto A, Mammoto T, Luria A, Benny O, Chaponis DM, Dudley AC, Greene ER, Vergilio JA, Pietramaggiori G, Scherer-Pietramaggiori SS, Short SM, Seth M, Lih FB, Tomer KB, Yang J, Schwendener RA, Hammock BD, Falck JR, Manthati VL, Ingber DE, Kaipainen A, D'Amore PA, Kieran MW, Zeldin DC.

J Clin Invest. 2012 Jan;122(1):178-91. doi: 10.1172/JCI58128. Epub 2011 Dec 19.

32.

EET signaling in cancer.

Panigrahy D, Greene ER, Pozzi A, Wang DW, Zeldin DC.

Cancer Metastasis Rev. 2011 Dec;30(3-4):525-40. doi: 10.1007/s10555-011-9315-y. Review.

33.

Regulation of inflammation in cancer by eicosanoids.

Greene ER, Huang S, Serhan CN, Panigrahy D.

Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):27-36. doi: 10.1016/j.prostaglandins.2011.08.004. Epub 2011 Aug 16. Review.

34.

Cytochrome P450-derived eicosanoids: the neglected pathway in cancer.

Panigrahy D, Kaipainen A, Greene ER, Huang S.

Cancer Metastasis Rev. 2010 Dec;29(4):723-35. doi: 10.1007/s10555-010-9264-x. Review.

35.

The anti-angiogenic peptide, loop 6, binds insulin-like growth factor-1 receptor.

Fernandez CA, Roy R, Lee S, Yang J, Panigrahy D, Van Vliet KJ, Moses MA.

J Biol Chem. 2010 Dec 31;285(53):41886-95. doi: 10.1074/jbc.M110.166439. Epub 2010 Oct 12.

36.

Broad spectrum antiangiogenic treatment for ocular neovascular diseases.

Benny O, Nakai K, Yoshimura T, Bazinet L, Akula JD, Nakao S, Hafezi-Moghadam A, Panigrahy D, Pakneshan P, D'Amato RJ.

PLoS One. 2010 Sep 1;5(9). pii: e12515. doi: 10.1371/journal.pone.0012515.

37.

Inhibition of tumor angiogenesis by oral etoposide.

Panigrahy D, Kaipainen A, Butterfield CE, Chaponis DM, Laforme AM, Folkman J, Kieran MW.

Exp Ther Med. 2010 Sep;1(5):739-746. Epub 2010 Jul 21.

38.

PPARs and Anticancer Therapies.

Robbins ME, Linard C, Panigrahy D.

PPAR Res. 2010;2010:536415. doi: 10.1155/2010/536415. Epub 2010 Jun 8. No abstract available.

39.

PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.

Panigrahy D, Kaipainen A, Huang S, Butterfield CE, Barnés CM, Fannon M, Laforme AM, Chaponis DM, Folkman J, Kieran MW.

Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):985-90. doi: 10.1073/pnas.0711281105. Epub 2008 Jan 16.

40.

Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: potential for regulation of tumor growth.

Fannon M, Forsten-Williams K, Nugent MA, Gregory KJ, Chu CL, Goerges-Wildt AL, Panigrahy D, Kaipainen A, Barnes C, Lapp C, Shing Y.

J Cell Physiol. 2008 May;215(2):434-41. doi: 10.1002/jcp.21327.

41.

PPARs: A Double-Edged Sword in Cancer Therapy?

Panigrahy D, Kaipainen A, Kieran MW, Huang S.

PPAR Res. 2008;2008:350351. doi: 10.1155/2008/350351. Epub 2009 Jun 29. No abstract available.

42.

PPARalpha deficiency in inflammatory cells suppresses tumor growth.

Kaipainen A, Kieran MW, Huang S, Butterfield C, Bielenberg D, Mostoslavsky G, Mulligan R, Folkman J, Panigrahy D.

PLoS One. 2007 Feb 28;2(2):e260.

43.

PPARgamma as a therapeutic target for tumor angiogenesis and metastasis.

Panigrahy D, Huang S, Kieran MW, Kaipainen A.

Cancer Biol Ther. 2005 Jul;4(7):687-93. Epub 2005 Jul 13. Review.

PMID:
16082179
44.

Tumor-associated endothelial cells with cytogenetic abnormalities.

Hida K, Hida Y, Amin DN, Flint AF, Panigrahy D, Morton CC, Klagsbrun M.

Cancer Res. 2004 Nov 15;64(22):8249-55.

45.

Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs).

Duensing A, Medeiros F, McConarty B, Joseph NE, Panigrahy D, Singer S, Fletcher CD, Demetri GD, Fletcher JA.

Oncogene. 2004 May 13;23(22):3999-4006.

PMID:
15007386
46.

Therapeutic potential of thiazolidinediones as anticancer agents.

Panigrahy D, Shen LQ, Kieran MW, Kaipainen A.

Expert Opin Investig Drugs. 2003 Dec;12(12):1925-37. Review.

PMID:
14640937
47.

PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis.

Panigrahy D, Singer S, Shen LQ, Butterfield CE, Freedman DA, Chen EJ, Moses MA, Kilroy S, Duensing S, Fletcher C, Fletcher JA, Hlatky L, Hahnfeldt P, Folkman J, Kaipainen A.

J Clin Invest. 2002 Oct;110(7):923-32.

48.

Adipose tissue mass can be regulated through the vasculature.

Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, Folkman MJ.

Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10730-5. Epub 2002 Jul 29.

50.

Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.

Beecken WD, Fernandez A, Panigrahy D, Achilles EG, Kisker O, Flynn E, Joussen AM, Folkman J, Shing Y.

Urology. 2000 Sep 1;56(3):521-6.

PMID:
10962337

Supplemental Content

Loading ...
Support Center